SciSparc (SPRC) Competitors $0.28 +0.01 (+4.43%) Closing price 04/17/2025 03:59 PM EasternExtended Trading$0.27 -0.01 (-3.04%) As of 04/17/2025 05:50 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SPRC vs. SPRB, INAB, QNTM, SYBX, AFMD, MEIP, IMNN, CLDI, ORGS, and SLGLShould you be buying SciSparc stock or one of its competitors? The main competitors of SciSparc include Spruce Biosciences (SPRB), IN8bio (INAB), Quantum Biopharma (QNTM), Synlogic (SYBX), Affimed (AFMD), MEI Pharma (MEIP), Imunon (IMNN), Calidi Biotherapeutics (CLDI), Orgenesis (ORGS), and Sol-Gel Technologies (SLGL). These companies are all part of the "pharmaceutical products" industry. SciSparc vs. Spruce Biosciences IN8bio Quantum Biopharma Synlogic Affimed MEI Pharma Imunon Calidi Biotherapeutics Orgenesis Sol-Gel Technologies Spruce Biosciences (NASDAQ:SPRB) and SciSparc (NASDAQ:SPRC) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, media sentiment, analyst recommendations, institutional ownership, community ranking, risk and valuation. Do analysts prefer SPRB or SPRC? Spruce Biosciences presently has a consensus target price of $2.17, indicating a potential upside of 1,725.33%. Given Spruce Biosciences' stronger consensus rating and higher possible upside, equities analysts clearly believe Spruce Biosciences is more favorable than SciSparc.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Spruce Biosciences 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00SciSparc 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the media favor SPRB or SPRC? In the previous week, Spruce Biosciences had 8 more articles in the media than SciSparc. MarketBeat recorded 9 mentions for Spruce Biosciences and 1 mentions for SciSparc. SciSparc's average media sentiment score of 1.00 beat Spruce Biosciences' score of 0.06 indicating that SciSparc is being referred to more favorably in the news media. Company Overall Sentiment Spruce Biosciences Neutral SciSparc Positive Do insiders & institutionals have more ownership in SPRB or SPRC? 91.7% of Spruce Biosciences shares are held by institutional investors. Comparatively, 25.1% of SciSparc shares are held by institutional investors. 9.1% of Spruce Biosciences shares are held by company insiders. Comparatively, 1.5% of SciSparc shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has preferable valuation and earnings, SPRB or SPRC? SciSparc has lower revenue, but higher earnings than Spruce Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSpruce Biosciences$7.10M0.69-$47.92M-$0.94-0.13SciSparc$1.75M1.75-$5.12MN/AN/A Which has more risk & volatility, SPRB or SPRC? Spruce Biosciences has a beta of 2.39, suggesting that its share price is 139% more volatile than the S&P 500. Comparatively, SciSparc has a beta of 0.65, suggesting that its share price is 35% less volatile than the S&P 500. Does the MarketBeat Community prefer SPRB or SPRC? Spruce Biosciences received 37 more outperform votes than SciSparc when rated by MarketBeat users. However, 66.67% of users gave SciSparc an outperform vote while only 54.17% of users gave Spruce Biosciences an outperform vote. CompanyUnderperformOutperformSpruce BiosciencesOutperform Votes3954.17% Underperform Votes3345.83% SciSparcOutperform Votes266.67% Underperform Votes133.33% Is SPRB or SPRC more profitable? SciSparc has a net margin of 0.00% compared to Spruce Biosciences' net margin of -555.23%. SciSparc's return on equity of 0.00% beat Spruce Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Spruce Biosciences-555.23% -62.10% -47.49% SciSparc N/A N/A N/A SummarySpruce Biosciences beats SciSparc on 8 of the 15 factors compared between the two stocks. Get SciSparc News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SPRC vs. The Competition Export to ExcelMetricSciSparcPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.06M$6.44B$5.30B$7.34BDividend YieldN/A3.21%5.45%4.30%P/E RatioN/A6.8921.8617.80Price / Sales1.75230.51380.5297.73Price / CashN/A65.6738.2634.64Price / Book0.025.936.453.98Net Income-$5.12M$142.99M$3.22B$247.81M1 Month Performance-14.93%-13.57%-9.71%-7.84%1 Year Performance-77.02%-8.90%11.51%1.60% SciSparc Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SPRCSciSparc0.7094 of 5 stars$0.28+4.4%N/A-78.1%$3.06M$1.75M0.004Short Interest ↓Positive NewsGap UpSPRBSpruce Biosciences2.7794 of 5 stars$0.31+8.0%$2.50+695.2%-83.1%$12.99M$7.10M-0.3320Earnings ReportAnalyst ForecastShort Interest ↓Analyst RevisionNews CoveragePositive NewsGap UpINABIN8bio3.4181 of 5 stars$0.16+4.7%$6.00+3,668.8%-84.7%$12.94MN/A-0.2120Short Interest ↓Positive NewsQNTMQuantum BiopharmaN/A$6.72-3.2%N/AN/A$12.90MN/A-0.44N/AGap DownSYBXSynlogicN/A$1.10+7.3%N/A-42.1%$12.87M$8,000.00-0.2680AFMDAffimed3.529 of 5 stars$0.79+27.2%$13.50+1,606.9%-85.5%$12.73M$877,000.000.00200Analyst ForecastNews CoverageGap UpMEIPMEI Pharma2.2334 of 5 stars$1.91+2.1%N/A-39.4%$12.73M$65.30M-0.33100Analyst ForecastShort Interest ↓IMNNImunon1.634 of 5 stars$0.87+2.4%$21.50+2,371.3%-20.9%$12.72M$500,000.00-0.4630Short Interest ↑Negative NewsCLDICalidi Biotherapeutics2.289 of 5 stars$0.43-1.4%$15.00+3,357.0%N/A$12.35M$50,000.000.0038News CoverageGap UpORGSOrgenesisN/A$2.50+26.9%N/AN/A$12.00M$662,000.000.00150Upcoming EarningsGap DownSLGLSol-Gel Technologies1.9903 of 5 stars$0.43-0.4%$5.00+1,067.1%-41.8%$11.93M$11.71M-1.2650News CoverageGap Up Related Companies and Tools Related Companies SPRB Alternatives INAB Alternatives QNTM Alternatives SYBX Alternatives AFMD Alternatives MEIP Alternatives IMNN Alternatives CLDI Alternatives ORGS Alternatives SLGL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SPRC) was last updated on 4/19/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsElon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SciSparc Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share SciSparc With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SPRC Stock Free SPRC Stock Alerts